IL-11 Antikörper

Chen, Chen, Xie, Huang, Dong, Han, Zhang, Zhou, Li, Huang, Lin: "DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 27, Issue 2, pp. 326-341, (2019) (PubMed).

Zhao, Liu, Liu, Qi, Hou, Chang, Ren: "Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 45, Issue 6, pp. 2213-2224, (2018) (PubMed).

Sano, Takei, Ueda, Tsumoto: "Production and characterization of genetically modified human IL-11 variants." in: Biochimica et biophysica acta. General subjects, Vol. 1861, Issue 2, pp. 205-217, (2017) (PubMed).

Pan, Xu, Liu, Zhang, Liu, Liu, Fu, Xu: "High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma." in: Cancer science, Vol. 106, Issue 5, pp. 592-7, (2015) (PubMed).

Zhang, Tao, Chopra, Dujmovic-Basuroski, Jin, Tang, Drulovic, Markovic-Plese: "IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 194, Issue 11, pp. 5139-49, (2015) (PubMed).

Zhou, Ji, Cai, Shi, Chen, Yu, Zhu, Zhang: "MTA2 enhances colony formation and tumor growth of gastric cancer cells through IL-11." in: BMC cancer, Vol. 15, pp. 343, (2015) (PubMed).

Dams-Kozlowska, Kwiatkowska-Borowczyk, Gryska, Mackiewicz: "Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor." in: International journal of medical sciences, Vol. 10, Issue 9, pp. 1157-65, (2013) (PubMed).

Bockhorn, Dalton, Nwachukwu, Huang, Prat, Yee, Chang, Huo, Wen, Swanson, Qiu, Lu, Park, Dolan, Perou, Olopade, Clarke, Greene, Liu: "MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11." in: Nature communications, Vol. 4, pp. 1393, (2013) (PubMed).

Kim, Kim, Ham, Brown, Greene, DAgati, Lee: "IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI." in: Journal of the American Society of Nephrology : JASN, Vol. 24, Issue 10, pp. 1558-70, (2013) (PubMed).

Onnis, Fer, Rapisarda, Perez, Melillo: "Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells." in: The Journal of clinical investigation, Vol. 123, Issue 4, pp. 1615-29, (2013) (PubMed).